# Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)

> **NCT03963544** · — · COMPLETED · sponsor: **Institut Bergonié** · enrollment: 492 (actual)

## Conditions studied

- Gastro Intestinal Stromal Tumor

## Interventions

- **DRUG:** oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations

## Key facts

- **NCT ID:** NCT03963544
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1990-01
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 492 (ACTUAL)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963544, "Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03963544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*